Cardiac Surgery News and Research

RSS

TCFC completes two in-utero fetal cardiac interventions to treat HLHS

The team at Texas Children's Fetal Center, a national leader for treating fetal anomalies, has successfully completed two in-utero fetal cardiac interventions to treat hypoplastic left heart syndrome (HLHS), a congenital heart defect that is one of the most complex heart defects to treat.

5 May 2012

Abbott to purchase AP214 hormone analogue from Action Pharma

Abbott and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.

4 May 2012

Updated results from CircuLite’s Synergy miniature ventricular support system clinical study

CircuLite, Inc. today announced that updated clinical data related to the Synergy miniature ventricular support system was presented in two oral presentations and one poster session at the International Society for Heart and Lung Transplantation's 32nd Annual Meeting and Scientific Sessions (ISHLT) in Prague, Czech Republic.

21 Apr 2012

Johns Hopkins Heart and Vascular Institute to open new building on April 29

Patients with heart and vascular disease will be cared for in spacious, state-of-the-art private rooms when Johns Hopkins opens its new hospital building to the first patients on April 29. The Johns Hopkins Heart and Vascular Institute occupies a major part of the 1.6 million-square-foot facility, which has 560 all-private patient rooms with private baths and 33 expansive operating rooms.

19 Apr 2012

State roundup: Mass. seeks to improve medical malpractice system; Health exchange legislation progresses in Ala.

Seven Massachusetts hospitals plan to offer patients harmed by medical errors a prompt apology and financial settlements before they resort to lawsuits, part of a major new initiative to improve the state's cumbersome medical malpractice system. A coalition of physician, hospital, and patient groups planned to release details Wednesday of the initiative, called "Road Map to Reform,"' which they predict will increase reporting of medical mistakes and cut down on lengthy litigation that drives up health care costs and fuels distrust between caregivers and patients.

19 Apr 2012

SMART Heart improves cardiovascular surgical outcomes

Two years ago, 57-year-old Allus Brown underwent a simultaneous heart-kidney transplant and spent months in and out of the hospital after battling dilated cardiomyopathy, a condition that enlarges and weakens the heart. Now fully recovered, Brown is still in and out of Northwestern Memorial Hospital's Bluhm Cardiovascular Institute each week. Only nowadays when he visits, he's laughing it up, playing board games, and sharing accounts of his own struggles with heart disease as part of the Bluhm Institute's new and innovative program, SMART Heart, stress management and recreational therapy for heart patients.

16 Apr 2012

Roundup: Texas considers relaxing rules for stem cell treatments; States weigh bills to protect consumers against high drug costs

A Texas agency will vote Friday on whether to enact new rules that would make it easier for doctors to offer experimental treatments using adult stem cells without federal approval. The Texas Medical Board, which licenses and disciplines doctors in the state, recently drafted stem-cell rules at the behest of Dr. Stanley Jones of Houston, who in July injected Gov. Rick Perry with the governor's own stem cells to try to aid his recovery from a back injury.

16 Apr 2012

Viewpoints: Obama's 'diatribe' on Ryan budget; President 'recovers' on statements about the court; Other health care mandates

If there's a Laffer Curve for Presidential invective-;some point at which dishonest political abuse yields diminishing returns-;the White House political team must not think their boss has hit it. Even in this hyperpartisan age, President Obama's speech to the Associated Press yesterday was a parody of the form. This was a diatribe that managed to invoke "Social Darwinism" and "a Trojan Horse" in the same paragraph, amid the other high crimes that Mr. Obama says Paul Ryan wants to commit.

5 Apr 2012

Estech receives FDA IDE approval to initiate enrollment in TCRF ablation trial for AF

Estech, a leader in minimally invasive and endoscopic cardiac ablation, announced today that the Food and Drug Administration (FDA) has given conditional Investigational Device Exemption (IDE) approval to initiate patient enrollment in the Estech-sponsored ATTAC-AF trial.

3 Apr 2012

Johns Hopkins Hospital's new home to open on May 1

The Johns Hopkins Hospital's new home, set to open on May 1, will redefine the very essence of the hospital experience, and cutting-edge technology designed to improve care, streamline workflow and encourage efficiencies will play a central role.

31 Mar 2012

Study reveals clinically relevant differences between on pump and off pump bypass

A large randomized trial comparing bypass surgery done with a heart-lung machine (on pump) and without it (off pump) found no differences in results between techniques overall but some clinically relevant differences, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.

27 Mar 2012

Angioplasty can be safely and effectively performed at community hospitals

New evidence shows that with appropriate preparation, angioplasty can be safely and effectively performed at community hospitals without on-site cardiac surgery units, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.

27 Mar 2012

Lower BMI increases risk during insertion of ICDs

Patients who are underweight or small in stature are twice as likely to experience complications or die during insertion of an implantable cardioverter-defibrillator (ICD) compared to obese and normal-weight patients, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.

26 Mar 2012

Kips Bay Medical fourth quarter net sales decrease to $94,000

Kips Bay Medical, Inc. today announced financial results for fourth quarter and year ended December 31, 2011.

17 Mar 2012

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

CSL Behring announced today that the first patient has been treated as part of the REPLACE Phase III clinical trial evaluating the efficacy and safety of fibrinogen concentrate (Human) (FCH) in controlling microvascular bleeding during aortic aneurysm surgery.

16 Mar 2012

Cardiac Surgery News and Research

TCFC completes two in-utero fetal cardiac interventions to treat HLHS

Abbott to purchase AP214 hormone analogue from Action Pharma

Updated results from CircuLite’s Synergy miniature ventricular support system clinical study

Johns Hopkins Heart and Vascular Institute to open new building on April 29

State roundup: Mass. seeks to improve medical malpractice system; Health exchange legislation progresses in Ala.

SMART Heart improves cardiovascular surgical outcomes

Roundup: Texas considers relaxing rules for stem cell treatments; States weigh bills to protect consumers against high drug costs

Viewpoints: Obama's 'diatribe' on Ryan budget; President 'recovers' on statements about the court; Other health care mandates

Estech receives FDA IDE approval to initiate enrollment in TCRF ablation trial for AF

Johns Hopkins Hospital's new home to open on May 1

Study reveals clinically relevant differences between on pump and off pump bypass

Angioplasty can be safely and effectively performed at community hospitals

Lower BMI increases risk during insertion of ICDs

Kips Bay Medical fourth quarter net sales decrease to $94,000

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

Four leading organizations release recommendations to ensure optimal care of TAVR patients

U-M summit to focus on shortage of medical technologies for children

New protocol decreases sternum infections in kids by 61%

News briefs from featured presentations at Cardiology 2012

Teleflex, Premier enter new agreements for ligation and stapling products, suture and trocars

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News